BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29921021)

  • 1. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults.
    McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V
    Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.
    Voss MH; Lunning MA; Maragulia JC; Papadopoulos EB; Goldberg J; Zelenetz AD; Horwitz SM
    Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):8-14. PubMed ID: 23107915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
    Lauhan CR; Schiff D; Gloude N
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28528. PubMed ID: 32776434
    [No Abstract]   [Full Text] [Related]  

  • 4. A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma.
    Moustafa MA; Ramdial JL; Tsalatsanis A; Khimani F; Dholaria B; Bojanini L; Brooks T; Zain J; Bennani NN; Braunstein Z; Brammer JE; Beitinjaneh A; Jagadeesh D; Weng WK; Kumar A; Kharfan-Dabaja MA; Ahmed S; Murthy HS
    Transplant Cell Ther; 2024 May; 30(5):516.e1-516.e10. PubMed ID: 38431075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
    Wang Q; Jiang Y; Zhu Q; Duan Y; Chen X; Xu T; Jin Z; Li C; Wu D; Huang H
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3441-3445. PubMed ID: 33856526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
    Okuni M; Yakushijin K; Uehara K; Ichikawa H; Suto H; Hashimoto A; Tanaka Y; Shinzato I; Sakai R; Mizutani Y; Nagao S; Kurata K; Kakiuchi S; Miyata Y; Inui Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Matsuoka H; Minami H
    Intern Med; 2019 Mar; 58(5):707-712. PubMed ID: 30449784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.
    Schafer E; Chen A; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1127-9. PubMed ID: 19479793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
    Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.
    Chanan-Khan A; Islam T; Alam A; Miller KC; Gibbs J; Barcos M; Czuczman MS; Paplham P; Hahn T; McCarthy P
    Leuk Lymphoma; 2004 Aug; 45(8):1673-5. PubMed ID: 15370223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
    Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
    Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
    Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
    Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
    Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
    Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
    Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
    Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
    Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
    Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.
    Calvaruso M; Gulino A; Buffa S; Guarnotta C; Franco G; Cacciatore M; Bonura MG; Franco V; Florena AM
    Leuk Lymphoma; 2014 Nov; 55(11):2457-65. PubMed ID: 24506469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
    Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
    Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatosplenic T-cell lymphoma: treatment challenges.
    Bron D; De Leval L; Michiels S; Wittnebel S;
    Curr Opin Oncol; 2021 Sep; 33(5):406-411. PubMed ID: 34409955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.